CXCR2 and prostate cancer: The overexpression of CXCL3 and its receptor CXCR2 promoted the proliferation and migration of cancer cells by regulating the expression of genes, including ERK, BAX, TP73, and NDRG3, which enhance the oncogenic potential of prostate cancer (Gui et al., 2016).